Neuropsychopharmacology
- Toward scalable biomarkers: the promise of sleep wearables in neurodevelopmental research3 months ago
- For those with schizophrenia, does cannabidiol make cannabis use safer?3 months ago
- Leveraging high-resolution brain imaging and (epi)genomic approaches to improve women’s mental health3 months ago
- Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning4 months ago
- Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia4 months ago
- Hearing and early life adversity: effects of developmental stress on sensory processing4 months ago
- The role of the prelimbic cortex to nucleus accumbens core projection in the reinstatement of cocaine-seeking after cocaine-alcohol polysubstance use4 months ago
Journal of Psychopharmacology
- GABA and Glx levels in cortico-subcortical networks predict catecholaminergic effects on response inhibition6 months ago
- Adolescent substance use trajectories are associated with nucleus accumbens functional connectivity6 months ago
- Development and validation of the Comprehensive Cannabis Motives Questionnaire (CCMQ)6 months ago
- Ethanol-induced rapid eye movement sleep suppression in rats: Comparison with subtype-selective GABAA receptor compounds6 months ago
- Nucleus accumbens serotonin 1A receptor expression is altered by female reproduction and regulates postpartum affective and caregiving behaviors6 months ago
- Functional connectivity alterations of the pregenual anterior cingulate cortex by ketamine and the modulation by lamotrigine6 months ago
- Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects6 months ago
European Neuropsychopharmacology
- Exploring the prospective association of serum interleukin-1β and brain-derived neurotrophic factor with antidepressant treatment response8 months ago
- Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study8 months ago
- Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”8 months ago
- Longitudinal brain age in first-episode mania youth treated with lithium or quetiapine8 months ago
- Egr2 Modulation in the Medial Prefrontal Cortex Regulates Resistance to Stress-Induced Memory Impairments8 months ago
- Creatine as a treatment for depression: A brain bioenergetics perspective8 months ago
- Rethinking suicide prediction: From static risk factors to dynamic models8 months ago